Young Investigator Awards from the Bladder Cancer Advocacy Network support early-career cancer researchers studying bladder and upper tract urothelial cancer to improve understanding, treatment, and patient experience.
Patient-Centered Clinical Research Award supports investigators launching patient-centered research careers, funding new studies to improve treatment, care, and experiences for people with bladder cancer.
The 2026 BCAN Continuity Grant supports U.S. investigators whose bladder cancer research lost federal funding or narrowly missed NIH funding, helping scientifically reviewed projects continue.
Supports innovative research to discover and investigate new targets or biomarkers for kidney cancer, encouraging basic, translational, and clinical science that could lead to new treatments.
Supports early career scientists conducting bold, high-risk cancer research with the potential for transformative advances in prevention, diagnosis, treatment, or understanding.